Ingredient
Dryopteris Crassirhizoma Extract
Dryopteris Crassirhizoma Extract is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is absorbed into the body.
- Male Fern Extract
- Dryopteris Extract
- Thick-Stemmed Wood Fern Extract
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Dryopteris Crassirhizoma Extract and pregnancy
Caution Advised
- Absorbed into the body
Dryopteris crassirhizoma extract comes from the male fern plant, which has been used in traditional medicine but also carries a history of toxicity concerns when consumed internally. The extract contains various phloroglucinol compounds and other bioactive substances that give it antioxidant properties in cosmetic formulations. While topical use differs significantly from internal consumption, there are no published studies on the safety of this fern extract during pregnancy. The concern stems from the plant's known toxicity profile in traditional medicine when taken orally, where male fern has been documented to cause adverse effects. Without specific data on dermal absorption rates or safety in pregnancy, and given the plant's toxicological history, caution is warranted. No major obstetric organizations have specifically evaluated this ingredient, as it is not commonly used in Western cosmetics. Due to the lack of safety data and the plant's historical toxicity concerns, many healthcare providers would recommend choosing better-studied botanical extracts during pregnancy. While topical risk may be low, the absence of reassuring data supports a conservative approach.
Dryopteris Crassirhizoma Extract and breastfeeding
Caution Advised
Dryopteris crassirhizoma extract is a botanical ingredient derived from fern rhizome. When applied topically in cosmetic products, the amount absorbed systemically would typically be minimal, but the specific absorption characteristics and bioavailability of its active compounds have not been well studied. There is no available data on whether the bioactive compounds in this fern extract can transfer into breast milk or what effects they might have on breastfed infants. The plant has a history of toxicity concerns in traditional medicine contexts, though these relate to oral consumption rather than topical application. Without safety studies specific to lactation, it's difficult to provide definitive guidance. Given the lack of breastfeeding safety data and the plant's toxicological history, a conservative approach would be to choose alternative botanical extracts with better-established safety profiles. While topical use may pose minimal risk, better-studied antioxidant ingredients are readily available and would provide similar cosmetic benefits with greater confidence in their safety profile.
Dryopteris Crassirhizoma Extract and postpartum
Safe to Use
- Irritant
For postpartum women who are not breastfeeding, Dryopteris crassirhizoma extract presents fewer concerns than during pregnancy or lactation. The ingredient's antioxidant properties may provide some skin benefits, and without concerns about fetal exposure or milk transfer, the primary consideration becomes topical tolerability. The main consideration is potential for skin irritation, as fern extracts can be sensitizing for some individuals. Starting with products containing lower concentrations and monitoring for any adverse reactions is advisable. Women with sensitive skin or those experiencing postpartum skin sensitivity may want to patch test products containing this ingredient.
Dryopteris Crassirhizoma Extract and trying to conceive
Caution Advised
Dryopteris crassirhizoma extract lacks specific safety data for women trying to conceive. Given the plant's historical toxicity profile when consumed internally, and the absence of studies on its effects during the periconception period, a conservative approach is appropriate. While topical use is unlikely to cause significant systemic absorption, women trying to conceive may prefer to switch to better-studied botanical ingredients with established safety profiles. This allows for seamless continuation into pregnancy without needing to change products. The precautionary principle suggests choosing ingredients with more comprehensive safety data during this important period.
Dryopteris Crassirhizoma Extract and PCOS
Safe to Use
Dryopteris crassirhizoma extract is a botanical antioxidant with no known hormonal activity or effects on androgen metabolism. It does not contain phytoestrogens or other compounds that would interfere with hormonal balance in women with PCOS. The extract's anti-inflammatory and antioxidant properties may actually provide benefits for PCOS-related skin concerns. Many women with PCOS experience inflammation-related skin issues, and antioxidants can help protect skin from oxidative stress. There is no evidence that this ingredient would affect insulin sensitivity or worsen PCOS symptoms. There are no contraindications for using this extract with PCOS, and it does not interact with common PCOS medications. As with any botanical ingredient, individual tolerance may vary, so monitoring for skin irritation is recommended, particularly for those with sensitive skin.
Dryopteris Crassirhizoma Extract and general use
Safe to Use
- Irritant
Dryopteris crassirhizoma extract is a botanical ingredient used in cosmetics for its antioxidant and potential anti-inflammatory properties. It is more commonly found in Asian beauty products and is valued for traditional medicine associations. The extract contains various bioactive compounds that may help protect skin from environmental stressors. For the general population, the primary concern is potential for skin irritation or allergic reactions, as botanical extracts can be sensitizing for some individuals. The ingredient has not undergone extensive safety testing by major cosmetic regulatory bodies, which means less is known about its long-term safety profile compared to more commonly used cosmetic ingredients. Most adverse reactions would be limited to topical irritation. The extract is permitted in cosmetics where it is used, but consumers with sensitive skin may want to patch test products containing this ingredient. While it offers antioxidant benefits, many alternative botanical extracts with better-established safety profiles can provide similar effects.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Dryopteris Crassirhizoma Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store